Status:
COMPLETED
Intervention With n3 LC-PUFA-supplemented Yogurt
Lead Sponsor:
University of Jena
Conditions:
Moderate Hypertriacylglycerolemic Subjects
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
The effective dosage of a n3-LC-PUFA intervention (with n3 LC-PUFA-enriched yoghurt) on the modulation of cardiovascular risk factors and inflammatory biomarkers were determined.
Detailed Description
Fifty three mildly hypertriacylglycerolemic subjects (TAG ≥ 150 mg/dL (1.7 mmol/L)) participated on the placebo-controlled, double-blind, parallel designed study. The subjects consumed placebo yoghur...
Eligibility Criteria
Inclusion
- hypertriacylglycerolemic subjects (TAG: ≥ 150 mg/dl (1.7 mmol/l))
Exclusion
- patients receiving blood-diluting and lipid-lowering medications or glucocorticoids
- patients suffering from gastrointestinal or metabolic diseases (e.g., diabetes mellitus, hyper- and hypothyroidism) and hypercholesteremic patients with familial previous impacts
- patients taking dietary supplements (e.g., fish oil capsules, vitamin E) or having either known allergies or foodstuff indigestibility
- further exclusion criteria: smoking, high sportive activity or daily alcohol intake
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT01244048
Start Date
February 1 2009
End Date
April 1 2009
Last Update
March 7 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Jena, Institute of Nutrition, Department of Nutritional Physiology
Jena, Germany, 07743